<DOC>
	<DOCNO>NCT01024803</DOCNO>
	<brief_summary>Patients suffer hereditary retinal degeneration receive retinal implant restore sight . Subretinal implant `` ON '' result significant visual acuity improvement , compare `` OFF '' condition .</brief_summary>
	<brief_title>Safety Efficacy Subretinal Implants Partial Restoration Vision Blind Patients</brief_title>
	<detailed_description />
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Retinal Degeneration</mesh_term>
	<criteria>Hereditary retinal degeneration outer retinal layer i.e . photoreceptor rod &amp; cone . Pseudophakia Angiography show retinal vessel adequately perfuse , despite pathological RP condition . Age 18 78 year . Blindness ( least monocular ) i.e . visual function appropriate localization object , self sustain navigation orientation . Ability read normal print earlier life , optically correct without magnify glass . Willing able give write informed consent accordance EN ISO 14155 ( section 6.7 ) local legislation prior participation study . Able perform study full time period one year Module2 . Period appropriate visual function approx . 12 year / lifetime . Optical Coherence Tomography ( OCT ) show significant retina edema &amp; /or scar tissue within target region implant . Retina detect thin expect require restfunctionality inner retina show via Optical Coherence Tomography ( OCT ) . Lack innerretinal function , determine Electrically Evoked Phosphenes ( EEP ) . Heavy clump pigmentation posterior pole Any ophthalmologic disease relevant effect upon visual function ( e.g . glaucoma , optic neuropathy , trauma , diabetic retinopathy , retinal detachment ) . Amblyopia report earlier life eye implant Systemic disease might imply considerable risk regard surgical intervention anaesthesia ( e.g . cardiovascular/ pulmonary disease , severe metabolic disease ) . Neurological and/or psychiatric disease ( e.g . M. Parkinson , epilepsy , depression ) . Hyperthyroidism hypersensitivity iodine Women pregnant nursing , woman childbearing potential willing use medically acceptable mean birth control duration study , woman unwilling perform pregnancy test enter study . Participation another interventional clinical trial within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Retina implant , Subretinal</keyword>
	<keyword>Legal blindness</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
	<keyword>Eye Diseases</keyword>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>Retinitis</keyword>
	<keyword>Retinal Degeneration</keyword>
	<keyword>Eye Diseases , Hereditary</keyword>
	<keyword>Retinal Diseases</keyword>
</DOC>